Generation Bio Operating Income 2020-2023 | GBIO
Generation Bio operating income from 2020 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Generation Bio Annual Operating Income
(Millions of US $) |
| 2023 |
$-139 |
| 2022 |
$-141 |
| 2021 |
$-119 |
| 2020 |
$-81 |
| 2019 |
$-62 |
Generation Bio Quarterly Operating Income
(Millions of US $) |
| 2023-12-31 |
$-38 |
| 2023-09-30 |
$-31 |
| 2023-06-30 |
$-34 |
| 2023-03-31 |
$-35 |
| 2022-12-31 |
$-35 |
| 2022-09-30 |
$-33 |
| 2022-06-30 |
$-38 |
| 2022-03-31 |
$-35 |
| 2021-12-31 |
$-31 |
| 2021-09-30 |
$-32 |
| 2021-06-30 |
$-31 |
| 2021-03-31 |
$-26 |
| 2020-12-31 |
$-24 |
| 2020-09-30 |
$-21 |
| 2020-06-30 |
$-18 |
| 2020-03-31 |
$-18 |
| 2019-12-31 |
|
| 2019-09-30 |
$-16 |
| 2019-06-30 |
$-15 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.193B |
$0.006B |
|
Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass.
|
